Cell therapies, such as immune cell and stem cell therapies, are being preclinically and
clinically explored for the treatment of various diseases, but are often limited by low efficacy …

Immunotherapy has recently emerged as a promising therapeutic modality for the treatment
of various diseases such as cancer, inflammation, autoimmune diseases, and infectious …

Tumour-associated neutrophils can exert antitumour effects but can also assume a pro-
tumoural phenotype in the immunosuppressive tumour microenvironment. Here we show …

Tumor relapse and metastasis become a big challenge in treating malignant melanoma
because conventional therapeutic options often fail to eradicate the tumor residue after …

Traumatic brain injury (TBI) is a debilitating disease with no current therapies outside of
acute clinical management. While acute, controlled inflammation is important for debris …

Combinatorial methods to repolarize tumor-associated macrophages from anti-inflammatory
to pro-inflammatory phenotypes offer a promising route for cancer immunotherapy. However …

Adoptive cell therapy using natural killer (NK) cells emerges as the next‐generation cancer
immunotherapy. Based on the intrinsic capability of direct cancer cell necrosis without prior …

Dendritic cells (DCs) play a crucial role in initiating antitumor immune responses. However,
in the tumor environment, dendritic cells often exhibit impaired antigen presentation and …

Cell backpacks present significant potential in both therapeutic and diagnostic applications,
making it essential to further explore their interactions with host cells. Current evidence …

Cellular hitchhiking is an emerging strategy for the in vivo control of adoptively transferred
immune cells. Hitchhiking approaches are primarily mediated by adhesion of nano and …